production
Allergan recalls eye drugs after complaints of blurred vision
August 25, 2015Manufacturing and Production Allergan, manufacturing, product recalls, production, recalls
Allergan has issued a recall for batches of eye ointments sold in the US, after customers complained of foreign bodies …
FDA hits Mylan’s Indian plants with warning letter
August 20, 2015Manufacturing and Production Contamination, FDA, Mylan, Pfizer, manufacturing, production
The FDA has served Mylan with a warning letter citing contamination at three of its manufacturing facilities in India. Inspections …
GSK closes Legionella-hit US site
August 14, 2015Manufacturing and Production GSK, Legionnaire's disease, legionella, manufacturing, production
GSK has temporarily shut down its manufacturing site in North Carolina due to the discovery of the bacteria which causes …
US to lead global contract manufacturing market by 2020
August 11, 2015Manufacturing and Production APIs, United States, manufacturing, production
The global pharmaceutical contract manufacturing market was worth $58 billion in 2014 and is projected to reach $84 billion in 2020, according to a …
First 3D-printed drug approved by FDA
August 4, 2015Manufacturing and Production, Research and Development 3d printing, FDA, manufacturing, production
The world of medicine saw a new pharma milestone this week, with the first approval by the FDA of a …
Lupin buys Gavis to gain first US manufacturing site
July 28, 2015Manufacturing and Production Gavis, Lupin, manufacturing, production
Indian drug manufacturer Lupin is expanding to the US by purchasing Gavis pharma for $880 million, in a major boost …
FDA bans drug imports from Indian plant
July 21, 2015Manufacturing and Production Emcure, FDA, GMP, Good Manufacturing Practices, India, compliance, manufacturing, production, safety
The FDA has blocked US imports from the manufacturing plants of a major Indian pharmaceutical firm over safety fears. The …
Allergan closing manufacturing facility in Iceland
July 14, 2015Manufacturing and Production Actavis, Allergan, Iceland, manufacturing, production, redundancies
Actavis is shutting a plant in Iceland, where its recently-acquired company Actavis has roots, and cutting 300 jobs in the …
Actavis contraceptives recalled after packaging errors
July 9, 2015Manufacturing and Production Actavis, FDA, manufacturing, packaging, product recall, production, recalls
Actavis is voluntarily recalling more than half a million boxes of contraceptive pills in the United States due to problems …
Pfizer expands in China with $95m consumer products plant
June 16, 2015Manufacturing and Production, Sales and Marketing Asia, China, Pfizer, brett wells, production
Pfizer says it has broken ground with a $95 million production facility in Suzhou in China to expand its production …
BASF to build plant in US
May 8, 2012Manufacturing and Production BASF, Taylor, manufacturing, production
BASF has said it plans to build a new manufacturing facility for formic acid at its production site in Louisiana, …
Baxter planning $1 billion plasma facility for Atlanta
April 24, 2012Manufacturing and Production Atlanta, baxter, manufacturing, production
Baxter International has unveiled plans to build a major new manufacturing complex for its plasma-based therapies in Atlanta in the …
EMA completes review of Ben Venue-made drugs
March 19, 2012Manufacturing and Production Ben Venue, EMA, cancer drugs, production
The European Medicines Agency has recommended that manufacturing of two cancer medicines be transferred from Ben Venue Laboratories plant in …
Pharma manufacturing news in brief
March 19, 2012Manufacturing and Production Recipharm, manufacturing, production
Sweden’s Recipharm has been contracted by ViroPharma to carry out commercial-scale production of Plenadren (hydrocortisone modified release tablet), developed …
GSK-funded project will print APIs onto tablets
June 14, 2010Manufacturing and Production, Research and Development GlaxoSmithKline, manufacturing, production, tablets
Researchers at GlaxoSmithKline and two UK universities are working on a technology that could allow active pharmaceutical ingredients to be …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
